Hoffman Oncology
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer (NCT02626507) | Hoffman Oncology | 2016-01-01 |
Track Hoffman Oncology automatically
Every clearance here is in the API, with alerts when new ones post.